Thyroid test cost in Singapore — and why the guidelines don't want you testing it "just in case"

Last reviewed: August 2026 · Grade: Moderate (see full card on Blood Panels)

Thyroid-stimulating hormone (TSH) is the standard first-line thyroid screen: it rises when the thyroid is underactive and falls when it's overactive, making it a more sensitive early signal than the thyroid hormones themselves. It's near-universal on executive health packages, marketed as a "metabolism check," and one of the few tests on this site where the guideline verdict — insufficient evidence to screen everyone — sits at odds with how routinely it's sold. That's not a reason to skip it if you have symptoms or risk factors; it's a reason to understand exactly who the evidence supports testing.

What the evidence says

The U.S. Preventive Services Task Force's 2004 recommendation statement, "Screening for Thyroid Disease" (Ann Intern Med, PMID 14734336), concluded the evidence was insufficient to recommend for or against routine screening for thyroid disease in adults (Grade I). The Task Force's own review found fair evidence that TSH testing can detect subclinical thyroid disease in people without symptoms — the test itself works as a detector — but poor evidence that treating screen-detected, asymptomatic cases actually improves outcomes that matter to patients. That's the crux: detection isn't the bottleneck, proof that early treatment helps is. A separate 2015 USPSTF update (Ann Intern Med, DOI 10.7326/M15-0483) reached materially the same "insufficient evidence" conclusion for screening nonpregnant, asymptomatic adults, so this isn't a stale 2004 finding that's since been overturned.

None of this means TSH testing is low-value in general — it means the value is concentrated in specific groups. Subclinical hypothyroidism is common, especially in women over 60, and once someone has symptoms (fatigue, weight change, cold intolerance, palpitations), a goitre, a personal or family history of autoimmune/thyroid disease, a postpartum status, or is on a thyroid-affecting medication (amiodarone, lithium), the calculus changes entirely — testing is well-supported and clinically standard in those situations. The evidence gap is specifically about testing an asymptomatic, average-risk adult with no risk factors as a routine annual add-on.

Why this is Moderate, not Weak or Strong: Thyroid testing sits in the middle because the test itself is accurate and cheap, and the case for testing symptomatic or risk-factor-positive people is genuinely strong — that's not in dispute anywhere. What keeps it off Strong is that the single biggest reason people buy this test (as a blanket "check my thyroid" line item in a wellness package, with no symptoms or risk factors) is exactly the use case the USPSTF found insufficient evidence for. A test can be clinically indispensable for the right patient and a weak bet for the average asymptomatic buyer at the same time — that's the situation here.

Real Singapore pricing, 2026 — three providers compared

Three Singapore providers checked in August 2026. Thyroid testing is sold in tiers almost everywhere — a bare TSH, a TSH+FT4 pair, or a fuller panel adding FT3 and thyroid antibodies — and the tiers aren't priced consistently across providers, so a straight "cheapest" comparison is misleading unless you match tiers first:

Provider	Test	Price (SGD)	Notes
Shim Clinic	TSH (standalone)	S$30	Raw lab price listed as "$30" with no stated GST/consultation treatment; a separate consultation fee (from S$68 elsewhere on the site) typically applies to have the result reviewed.
Regis Medical	Basic Panel (TSH + Free T4)	S$45	Excludes consultation and GST. Extended Panel (+ Free T3) S$60; Comprehensive Panel (+ Anti-TPO, Anti-Thyroglobulin) from S$110. Page states prices last updated 1 April 2026.
ATA Medical	Thyroid Profile 1 (FT4 + TSH)	S$37.06	NETT, inclusive of GST. Thyroid Profile 5 (FT4 + TSH + FT3 + Anti-Thyroglobulin + Anti-TPO) S$95.92 NETT. Page states last updated 8 June 2026. TSH is not sold standalone here.

Matched tier-for-tier, ATA Medical's S$37.06 (FT4+TSH, GST-inclusive) is the more directly comparable "cheapest" figure against Regis Medical's S$45 equivalent Basic Panel (FT4+TSH, GST and consult excluded) — once GST is added to Regis's price, the two are close, not a wide spread. Shim Clinic's S$30 looks cheapest on paper, but it's TSH alone with no FT4 — the minimum first-line screen, not the pairing most clinicians would actually want to interpret a result properly. Going up to a fuller antibody-inclusive panel roughly triples the price at both Regis (to S$110+) and ATA (to S$95.92) — worth paying for if there's a specific reason to suspect autoimmune thyroid disease (e.g. Hashimoto's, Graves'), not worth it as a default add-on.

Practical tip: Start with TSH alone (or TSH+FT4, the more useful pairing). Free T4 only needs adding routinely if TSH comes back abnormal — most protocols reflex to FT4 automatically once TSH is out of range. Antibody testing (Anti-TPO, Anti-Thyroglobulin) is a second-line test for suspected autoimmune thyroid disease, not a first-pass screen — paying S$95–110 upfront for a full antibody panel with no prior abnormal result or symptoms is very likely money spent before it's needed.

Who should prioritise it

Testing is clearly worthwhile for anyone with symptoms suggestive of thyroid dysfunction (unexplained fatigue, weight change, palpitations, heat/cold intolerance, hair thinning), a palpable goitre, a personal or family history of thyroid or other autoimmune disease, a recent pregnancy (postpartum thyroiditis is common and underdiagnosed), or use of amiodarone or lithium. Women over 60 are a group worth a lower testing threshold given the higher background prevalence of subclinical disease. Outside those groups — a healthy, asymptomatic adult with no risk factors testing "just to check metabolism" — the USPSTF's own review found the evidence doesn't support a clear benefit, and a borderline or subclinical result in that population is as likely to generate anxiety and further testing as it is to change anything clinically meaningful.

Bottom line

At S$30–45 for a first-line TSH or TSH+FT4 pairing (rising to S$95–110+ for a full antibody panel), this is one of the cheaper tests on this site — the real cost isn't the money, it's ordering the wrong tier or ordering it without a reason. Thyroid testing is Moderate-graded because the evidence is genuinely strong for the symptomatic, risk-factor-positive, or postpartum patient, and explicitly rated insufficient by the USPSTF for routine screening of everyone else. Start with TSH(+FT4), reserve antibodies for a specific indication, and treat "why am I ordering this" as the more important question than which provider is a few dollars cheaper.